Health Care Stocks Down on Biosimilar Fears - Health Care Roundup
February 05 2016 - 4:41PM
Dow Jones News
The health-care sector fell amid concerns a new wave of generic
drugs could compete with newer biotechnology-based products. Shares
of AbbVie and Johnson & Johnson fell after U.S. Food and Drug
Administration documents hinted a cheaper competitor for the drug
companies' blockbuster anti-inflammatory treatments from a Korean
company could be headed to market soon. SciClone Pharmaceuticals
rose after the maker of a Hepatitis B treatment said it was
reviewing strategic alternatives, having settled a U.S. Securities
and Exchange Commission investigation into its China
operations.
-By Rob Curran, rob.curran@dowjones.com
(END) Dow Jones Newswires
February 05, 2016 16:26 ET (21:26 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024